Accelerate Diagnostics, Inc Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Accelerate Diagnostics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Accelerate Diagnostics, Inc for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 167,766 | 148.2 K to 167.8 K (+13.18 %) |
| Feb 23 2021 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Grant | A | 7.68 | 21,701 | 166,664 | 4,322,182 | 4.3 M to 4.3 M (+0.50 %) |
| Feb 23 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | PRESIDENT AND CEO | Grant | A | 7.68 | 4,340 | 33,331 | 14,848 | 10.5 K to 14.8 K (+41.30 %) |
| Feb 23 2021 | AXK | Accelerate Diagnos ... | Brown Thomas D | Director | Grant | A | 7.68 | 8,680 | 66,662 | 29,180 | 20.5 K to 29.2 K (+42.34 %) |
| Feb 23 2021 | AXK | Accelerate Diagnos ... | MILLER MARK C | Director | Grant | A | 7.68 | 13,020 | 99,994 | 13,020 | 0 to 13 K |
| Feb 04 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 9.87 | 54,132 | 534,283 | 1,262,023 | 1.2 M to 1.3 M (+4.48 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | M | 0.00 | 2,601 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Sell | S | 7.37 | 727 | 5,358 | 1,874 | 2.6 K to 1.9 K (-27.95 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Buy | M | 0.00 | 2,601 | 0 | 2,601 | 0 to 2.6 K |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | M | 0.00 | 2,601 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Sell | S | 7.37 | 727 | 5,358 | 1,874 | 2.6 K to 1.9 K (-27.95 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Buy | M | 0.00 | 2,601 | 0 | 2,601 | 0 to 2.6 K |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 40,000 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 10.90 | 3,313 | 36,112 | 10,508 | 13.8 K to 10.5 K (-23.97 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 10,000 | 0 | 13,821 | 3.8 K to 13.8 K (+261.71 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 40,000 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 10.90 | 3,313 | 36,112 | 10,508 | 13.8 K to 10.5 K (-23.97 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 10,000 | 0 | 13,821 | 3.8 K to 13.8 K (+261.71 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,363 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 7.37 | 1,542 | 11,365 | 3,821 | 5.4 K to 3.8 K (-28.75 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 5,363 | 0 | 5,363 | 0 to 5.4 K |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,363 | 0 | 0 | |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 7.37 | 1,542 | 11,365 | 3,821 | 5.4 K to 3.8 K (-28.75 %) |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 5,363 | 0 | 5,363 | 0 to 5.4 K |
| Feb 03 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 11.40 | 100,000 | 1,140,000 | 1,207,891 | 1.1 M to 1.2 M (+9.03 %) |
| Feb 02 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 10.18 | 30,868 | 314,236 | 1,107,891 | 1.1 M to 1.1 M (+2.87 %) |